NETRIS Pharma
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the pharmaceutical industry. The dependence receptors are trans-membrane proteins that receive signals and transmit them inside cells and this helps in controlling tumor development. The company provides vitro and in vivo research, preclinical practices for manufacturing drugs for the treatment of breast cancer, lung cancer, glioblastoma and neuroblastoma cancer.
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does NETRIS Pharma use?+
NETRIS Pharma uses 19 technologies including Bootstrap, Contact Form 7, jsDelivr.
What industry is NETRIS Pharma in?+
NETRIS Pharma operates in the Biotechnology industry.
Where is NETRIS Pharma based?+
NETRIS Pharma is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026